1.Introduction
Tuberculosis (TB) still remains one of the leading causes of morbidity and mortality in the world. At present one-third of the world's population is infected with Mycobacterium tuberculosis, the causative agent of TB. In 2011, one million people HIV negative and 'fourhundred and thirty thousand HIV positive died from the disease, 8.7 million new cases are estimated, of which 13% are coinfected with HIV (WHO, 2012) .
Pyrazinamide (PZA) is a first-line oral agent for TB short course chemotherapy. It is one of the few anti-TB drugs effective against persistent tubercle bacilli. It is only active against M. tuberculosis and M. africanum in the host, while M. bovis is inherently resistant to it. Since the global resurgence of drug resistant TB strains, an increasing number of PZA resistant strains have been observed. PZA is a prodrug which is converted into the active substance pyrazinoic acid (POA) by M. tuberculosis at low pH medium (Hewlett et al., 1995) , (Mc Dermott and Tompsett, 1954) , (Tarshis and Weed, 1953) .
In M. tuberculosis PZA is converted to POA by a 19.6 kDa pyrazinamidase (Rv2043c), encoded by pncA, a gene which spans 561 base pairs (Blanchard, 1996) . PZA susceptible M.
tuberculosis possesses a functional PZase, and mutations in this gene have been reported leading to reduction or complete loss of PZase activity, which in turn make the bacteria resistant to PZA (Butler and Kilburn, 1983; McClatchy et al., 1981; Trivedi and Desai, 1987) .
Despite a majority (70-97%) of PZA-resistant isolates of M. tuberculosis exhibit mutations in their pncA gene or putative regulatory region, PZA resistant isolates with PZase activity and wild type pncA sequences have also been reported in several studies, indicating the existence of alternate molecular mechanism of PZA-resistance (Ngo et al., 2007; Raynaud et al., 1999; Zhang and Mitchison, 2003) . Recently the 30S ribosomal protein S1 (rpsA) was found to bind to POA and subsequently inhibiting trans-translation. Mutations in the rpsA gene were associated with PZA resistance in clinical isolates without mutations in pncA (Shi et al., 2011) . We studied the relation between PZA resistance, PZase activity and mutations in pncA and or rpsA in clinical strains isolated from TB patients in a highly endemic area of Brazil, Rio de Janeiro state (57.6/100.000 inhab).
2.Materials and methods

2.1.Clinical strains and identification
A total of 97 M. tuberculosis clinical strains were exclusively isolated from sputum samples tuberculosis complex by biochemical tests such as: nitrate reduction, niacin production and catalase activity (Kent, 1985) .
2.2.Drug susceptibility testing and PZase activity assay
The M. tuberculosis isolates were tested for PZA susceptibility by proportion method in LJ medium pH 5.5 -5.8 with PZA at 100 µg/ml (Singh et al., 2007) . In addition the isolates were tested for streptomycin (STM), isoniazid (INH), ethambutol (EMB) and rifampicin (RPM) susceptibility using the standard proportion method on Löwenstein-Jensen medium. An isolate was defined as resistant when the percentage of colonies exceeded 1% of the growth on a drug-free medium (control) at the critical concentrations of 4, 0.2, 2, and 40 μg/mL, respectively (Canetti et al., 1969) . Multidrug resistance (MDR) is defined as resistance to at least INH and RMP, resistance to two or more drugs but not to MDR was assigned as drug -5 -resistance, and resistance to any one drug as monoresistant. PZase activity was determined using a modified method described by Wayne (Wayne, 1974) . In brief, a heavy loopful of mycobacterial culture freshly grown on LJ medium was inoculated in two 16 x 125 mm glass tubes with screw cap containing 5 ml Dubos broth medium supplemented with 100 µg/ml PZA and 2 mg/ml sodium pyruvate. After incubation at 37°C for 4 or 7 days (when negative at the fourth day the second tube was incubated for three more days), 1 ml of freshly prepared 1% ferrous ammonium sulphate solution was added to each tube, and the presence of a pink band was assessed. M. tuberculosis H37Rv and M. fortuitum were used as a positive and negative control respectively for the assay. Strains giving discordant results in phenotypic and genotypic analysis were retested for PZA susceptibility (proportion method and BACTEC Mycobacteria Growth Indicator Tube (MGIT), as recommended by Bencton Dickinson) and PZase activity.
2.3.DNA isolation
Chromosomal DNA was isolated as described by van Embden et al. (1993) from a loopful of clearly visible mycobacterial fresh growth in LJ. The purified DNA was dissolved in 20 µl of 0.1 x TE buffer and stored at -20C until used. DNA concentration was defined using a spectrophotometer Nanodrop 1000 (ThermoScientific, USA).
2.4.PCR and sequencing
The gene pncA was amplified with the pair of primer pncA-F and pncA-R which produced followed by 30 cycles of sequentially denaturation at 95°C for 30 sec, annealing at 57°C for 30 sec and polymerization at 72°C for 50 sec. The final annealing was done at 95°C for 10 minutes. Sequencing of pncA was done with the primers pncA-F, pncA-R, pncA-sf1, pncAsf2, pncA-sr1, pncA-sr2. For the detailed analysis of the pncA promoter region and additional 454 nucleotides upstream pncA, the primers Rv2044cF and Rv2044cR were used for amplification and sequencing. The PCR was carried out as described for pncA except 30 seconds were used for the extension step. The IS element of strain number 13 was analyzed with the primers Transp-sf and Transp-sf. All primers which were used for amplification and sequencing of pncA are summarized in Table 1 and Fig. 1 .
Sequencing of rpsA was done with the primers rpsA-F and rpsA-R (Table 1 ). The 1600 nt PCR product, included 130 nt upstream of the gene. RpsA was amplified with BioMix (Bioline GmbH, Germany). The PCR was performed as described for pncA except 100 seconds were used for elongation. The PCR products were purified with a QIAquick PCR purification kit (Qiagen GmbH, Hilden, Germany).
The sequencing of the extracted DNA was performed with an Automated 3730xl DNA Analyzer (Applied Biosystems, Inc, USA) using the same PCR primer set and sequencing primers ( Table 1 ). The DNA sequences were analysed by comparison with reference strain M. tuberculosis H37Rv DNA sequence using Pregap version 1.6 and Gap4 version 4.11 of Staden Package (Staden et al., 2000) . Mutations comparison was performed by searching in the TB Drug Resistance Mutation Data Base (Sandgren et al., 2009;  http://www.tbdreamdb.com/PZA_Rv2043c_HighConfidenceMutations.html). In 24 out of 35 PZA R isolates (68.6%) we could not detect PZase activity. This is a low correlation related to other studies, however similar (65.4%) found in Thailand (Jonmalung, 2010) . Sixteen of these 35 PZA R strains possessed mutation in the pncA gene (45.7%), and 62.5 % of PZase-negative strains possessed a mutation in the pncA gene, however concordance for all tests was 42.8 % (Table 2) .
3.Results
Characteristics of isolates
3.2.Distribution of mutations in the pncA gene
Among the studied strains the mutations in pncA were distributed throughout the gene as in previous studies (Barco et al., 2006; Lemaitre et al., 1999; Raynaud et al., 1999; Singh et al., 2007; Somoskovi et al., 2007) . Point mutations were observed in 14 strains, causing amino acid substitutions, which are located near the active site or metal binding site (active site: V7; metal site: D49, C72, T76) (Lemaitre et al., 1999; McClatchy et al., 1981; Scorpio et al., 1997; Somoskovi et al., 2007; Zhang and Mitchison, 2003) . Other isolates bearing different mutations at position 49 showed PZA-susceptibility as well as PZA-resistance. For example, isolates identified by the numbers n# 25, 37 and 47 have a D49A mutation in the pncA gene but show a contrasting phenotype concerning PZA susceptibility (Table 3) . Such contrasting results for strains bearing a mutation near the active site were also encountered in previous studies Hirano et al., 1997; Somoskovi et al., 2007; Sreevatsan et al., -8 -1997 ). Structure of PZase recently published showed the aspartic acid at position 49 binds directly to the metal in the enzyme (Petrella et al., 2011) . A summary of all observed mutations is shown in Fig. 1 . None of the analysed strains had mutation in putative promoter region of pncA. Even up to 454 nt upstream of pncA mutation was not observed (data not shown).
3.3.Insertions and analysis of IS6110
In five strains 8, 2 and 9 nt insertions (TCCTCGTC, CG, GAGGTCGAT) were observed between position 192-193, 444-445 and 388-389 respectively. The eight and nine nt inserts TCCTCGTC and GAGGTCGAT produced a short tandem repeat of (AGGTCGATG) 2 or (GAGGTCGAT) 2 and (TCCTCGTC) 2 in pncA gene respectively (Fig. 1) . The 9 nt insertion in codon 130 led to deletion of V130 and insertion of additional four amino acids. Though the insertion GAGGTCGAT between position 388-389 was previously reported (Sreevatsan et al., 1997) it was not known to produce tandem repeat as is being reported now. These repeats are very likely remains of a mobile element. This is supported by further finding of a strain comprising IS6110 located 96 nt upstream of the pncA gene (this study) and presence of IS6110 disrupting pncA (Lemaitre et al., 1999) .
3.4.Mutational analysis of the rpsA gene
None of the PZA-resistant strains harboured mutations in the rpsA gene.
Discussion
PZA resistance has been correlated with mutations in pncA gene, which codes for a pyrazinamidase, converting the prodrug PZA into POA. Correlation of drug resistance with a defect in a specific "drug resistant" gene is observed for several drugs. Resistance against ofloxacin, rifampicin, ethambutol, and isoniazid show variable correlation between the drug resistance phenotype and mutations in the drug resistance genes gyrA (75-94%), rpoB (90-95%), embB (47 -65%), and katG (31 -97 %)/inhA (8 -43 %), respectively (Kalokhe et al., 2012, Zhang and Yew, 2009 ).
In several studies the correlation of PZA resistance and mutation in pncA has also been reported in a variety of low range (41 -80%) (Bishop et al., 2001; Huang et al., 2003; Miyagi et al., 2004; Rodrigues et al., 2005; Chan et al., 2007; Pandey et al., 2009; Jonmalung et al., 2010) . while in other the correlation has been reported higher such in South Africa (91-92%) (Louw et al., 2006; Mphahlele et al., 2008) , China (91%) (Hou et al., 2000) , Japan (97%) (Hirano et al., 1997) , S. Korea (97%) (Lee et al., 2001 ). In the studied strains, only a correlation of 45.7% between PZA resistance and pncA mutation was observed which is far lower than the majority studies performed so far, including reports from low endemic area in Brazil (72% and 84%) (Rodrigues et al., 2005; Barco et al., 2006) , although similarly found in South Africa (67 %) and Taiwan (41 %) (Bishop et al., 2001; Huang et al., 2003) . Such a lower correlation might be attributed to some extend due to the limitation of phenotypic susceptibility test based on LJ proportion which was done at pH 5.5 -5.8 with 100 µg/ml PZA. False resistance is the most common cause of error in the results of susceptibility testing to PZA, and recently Simons et al. (2012) reported that this occurs under the influence of inoculum. The ammonia produced by bacterial metabolism lead to increases the pH of the culture medium and hence inactivation of the drug (Mc Dermott and Tompsett, 1954; Zhang et al., 2002) . However susceptibility testing was repeated carefully, including using MGIT for same discordant strains. The limitation of the test is not the sole reason for contribution of low correlation between PZA resistance and pncA mutation is supported by the presence of strains which were resistant depending on concentration of PZA used .
On the other hand, it is important to note that most of these strains are drug resistant or MDR and according to several authors resistance to PZA is associated with strains harboring multiple resistance to the first line drugs (>49 %), (Chang et al., 2011; Chiu et al., 2011; -10 -Fonseca et al., 2012; Kim et al., 2012; Louw et al., 2006; Minime-Lingoupou et al., 2010; Mphahlele et al., 2008; Shenai et al., 2009) . Frequency in pncA mutation among MDR strains was similar found in S. Korea (56.2 % x 63.9 %). So, it must have a reasonable explanation of the presence of these complex patterns which are most probably not a result of a defect in a single gene. The mutation found was diverse and scattered along the gene. Mutation is not always associated with resistance as described here and by other (Jonmalung et al, 2010) .
As the PZA susceptibility and pncA mutation were not highly correlated in the current studies, we also sequenced rpsA, which codes for the ribosomal protein S1, which has been reported as additional target for PZA resistance (Shi et al., 2011) . None of the resistant strains had a mutation in the rpsA gene. Recent study on analyse of PZA R strains reported rpsA gene has no impact on PZA resistance, although authors have found few mutations could not clearly associate with strains phenotypes (Alexander et al., 2012) .
The results show an a low association of PZA resistance with mutations in the pncA gene in isolates from patients living in a highly endemic area. The results jeopardize the use of methods which use pncA as sole indicator for the detection of PZA resistance. These informations may be helpful in the TB clinical practice for the selection and interpretation of diagnostic tests. 
